Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Neurology|November 2, 2012
Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3Renske I Wadman, Alexander F J E Vrancken, Leonard H van den Berg, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Drug treatment for spinal muscular atrophy types II and IIIRenske I Wadman, Wendy Mj Bosboom, Leonard H van den Berg, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Drug treatment for spinal muscular atrophy type IRenske I Wadman, Wendy Mj Bosboom, Leonard H van den Berg, et al.
International Journal of Molecular Sciences|November 25, 2023
A Novel Variant in TPM3 Causing Muscle Weakness and Concomitant Hypercontractile PhenotypeKatarzyna Robaszkiewicz, Małgorzata Siatkowska, Renske I Wadman, et al.
Muscle & Nerve|April 14, 2016
Correlates of health related quality of life in adult patients with spinal muscular atrophyEsther Th Kruitwagen-Van Reenen, Renske I Wadman, Johanna Ma Visser-Meily, et al.
The Cochrane Database of Systematic Reviews|February 2, 2020
Drug treatment for spinal muscular atrophy types II and IIIRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
Neurology|January 15, 2016
Mandibular dysfunction as a reflection of bulbar involvement in SMA type 2 and 3H Willemijn van Bruggen, Renske I Wadman, Ewald M Bronkhorst, et al.
Orphanet Journal of Rare Diseases|September 14, 2018
A continuous repetitive task to detect fatigability in spinal muscular atrophyMarloes Stam, Renske I Wadman, Bart Bartels, et al.
The Cochrane Database of Systematic Reviews|December 12, 2019
Drug treatment for spinal muscular atrophy type IRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
Neuromuscular Disorders : NMD|June 11, 2024
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3Danny R van der Woude, Renske I Wadman, Fay-Lynn Asselman, et al.
Pageof 5